Problems related to the febrile neutropenia in persons with cancer
Abstract
A bibliographical revision was carried out with the aim to recommend thean educational intervention strategy to prevent the febrile neutropenia in adult person with cancer in Ciego deAvila municipality. A search was carried out in different database available in Infomed, in order to determine tendencies from the application of certain instruments and techniques, these one were compared with national and foreigner updated literature. The recommended strategy of educational intervention will help to the control and prevention of febrile neutropenia in person with cancer by means of the prevention of problems related to this disease. It implements a guide for its initial handling, acting energetically in order to avoid the antimicrobial resistance that constitutes a feasible guide borne out by the experts' opinion.
Downloads
References
Organización Mundial de la Salud. Cáncer. Nota descriptiva No. 297 [Internet]. Washington: OPS; 2013 [citado 12 Feb 2013] [aprox. 3 pantallas]. Disponible en: http://www.ncbi.nlm.nih.gov/sites/entrez?db=mesh
Organización Panamericana de la Salud. El cáncer es la segunda causa de muerte en América Latina [Internet]. Washington: OPS; 2010 [citado 12 Feb 2013] [aprox. 2 pantallas]. Disponible en: http://new.paho.org/uru/index.php?option=com_content&task=view&id=216&Itemid=1
Céspedes Quevedo MC, Lavado Fernández JA, Almenares Elías B, Edward Seringe S, Padilla Arencibia M. Infección intrahospitalaria en pacientes con cáncer. MEDISAN [Internet]. 2010 [citado 12 Feb 2013]; 14(8): [aprox. 8 p.]. Disponible en: http://scielo.sld.cu/scielo.php?pid=S1029-30192010000800012&script=sci_arttext&tlng=en
Organización Panamericana de la Salud. Programas nacionales de control del cáncer: políticas y pautas para la gestión [Internet]. Washington: OPS; 2004 [citado 12 Feb 2013] [aprox. 17 pantallas]. Disponible en:
Sansó Soberats FJ, Alonso Galbán P, Torres Vidal RM. Mortalidad por cáncer en Cuba. Rev Cubana Salud Pública [Internet]. 2010 [citado 2013 Abr 23]; 36(1): 78-94. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-34662010000100009&lng=es).
Cavalli F. Cáncer. El gran desafío. La Habana: Ciencias Médicas; 2012.
Soler Santana R, Soler Santana AL, Carbonell García IC, Brossard Cisneros M. Mortalidad por tumores malignos en Santiago de Cuba durante 2010. MEDISAN [Internet]. 2011 [citado 27 Mar 2013]; 15(11): 1510-1516. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1029-30192011001100002&lng=es
Torres HA. Neutropenia febril: una revisión del tema [Internet]. 2004 [citado 6 Mar 2013] [aprox. 12 pantallas]. Disponible en: http://vitae.ucv.ve/pdfs/VITAE_3187.pdf
Neutropenia y fiebre [Internet]. 2011[citado 6 Mar 2013] [aprox. 5 pantallas]. Disponible en: ttp://www.intramed.net/sitios/librovirtual1/pdf/librovirtual1_55.Pdf
Lyman G, Michels S, Reynolds M, Barron R, Smoyer Tomic K, Yu J. Risk of Mortality in Patients With Cancer Who Experience Febrile Neutropenia. Cancer [Internet]. 2010 [citado 12 Mar 2013]. [aprox. 12 pantallas]. Disponible en: http://onlinelibrary.wiley.com/doi/10.1002/cncr.25332/full
Kim P, Wu Y, Cooper Ch, Rochester G, Valappil T, Wang Y, et al. Meta-analysis of a possible signal of increased mortality associated with cefepime use. Clin Infect Dis. 2010; 51(4): 381-9.
Freifeld A, Bow E, Sepkowitz K, Boeckh M, Ito J, Mullen C, et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2011; 52(4): e56-93.
Gaytán-Martínez J, Ávila-Morán M, Mata-Marín JA, Mateos-García E, Fuentes-Allen JL, Vela-Ojeda J. et al. Patrones de susceptibilidad bacteriana en infecciones en pacientes adultos con neoplasias hematológicas, fiebre y neutropenia. Gaceta Méd México. 2011; 147: 325-32.
Paul M, Yahav D, Bivas A, Fraser A, Leibovivi. Anti-seudomonal betalactams for the initial, empirical, treatment of febrile neutropenia: comparison of betalactams (Review): Evid Based Child Health [Internet]. 2011[citado 12 mar 2013]; 6(6):2026-2185. Disponible en: http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD005197.pub3/pdf/standard
Feifled AG, Bovv EJ, Sepkovvitz KA. Clinical practice gudeline for the use of antimicrobial agents in neutropenic patients vvith cancer: 2010 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2011; 52:e56-e 93.
De Naurois J, Novitzky-Basso I, Guill MJ. Management of febrile neutropenia: ESMO Clinical Practice Guidelines. Ann Oncol. 2010; 21 (5): 252-6.
Goulart Rosa R. Impacto da aderência ao programa de controle de antimicrobianos na mortalidade de pacientes com neutropenia febril [Internet]. 2012[citado 12 Mar 2013]. [apro. 65 pantallas]. Disponible en: http://www.lume.ufrgs.br/handle/10183/53148
Garzón JR, Cuervo S, Gómez J, Cortés JA. Farmacocinética y farmacodinamia de antimicrobianos: A propósito de pacientes con neutropenia y fiebre. Rev Chil Infect. 2011; 28 (6): 537-545
Puentes GA, Quiroga C, Álvarez CA, Támara JR, Ruiz A. Características demográficas, morbilidad y mortalidad de los pacientes adultos con neutropenia febril tratados con cefepima. Rev Chilena Infectol. 2012; 29(3): 322-328.
Lami Casaus L, Arbesú Michelena MA, Sarmiento SA, Brito Iglesia R. Aparición de episodios de neutropenia febril tras la quimioterapia citostática en el paciente oncológico. Rev Cubana Farm. 2009; 43(4):68-73.
Al-Hasan MN, Eckel-Passow JE, Baddour LM. Cefepime effectiveness in Gram-negative bloodstream infections. J Antimicrob Chemother. 2011; 66: 1156 – 1160.
Downloads
Published
How to Cite
Issue
Section
License
MediCiego does not apply publication charges. The journal is available in open access without restrictions, in compliance with the international policy on open access to information for the exchange of global knowledge.
The authors will retain their copyright and guarantee the journal the right of first publication of their work. MediCiego is licensed under the Creative Commons Attribution-NonCommercial 4.0 International license (CC BY-NC 4.0) https://creativecommons.org/licenses/by-nc/4.0/deed.es_ES), so it is allowed to copy, reproduce, distribute, publicly communicate the work and generate derivative works, as long as the original author is cited and acknowledged. However, it is not allowed to use the original work for commercial or lucrative purposes.
Authors must sign a copyright agreement through an affidavit of authorship and originality, before publishing.
The authors authorize the publication of their writings; they retain the copyright, and assign to the journal all the rights protected by the Copyright Law that governs Cuba, and implies the edition to disseminate the work.
Likewise, they may establish additional agreements for the non-exclusive distribution of the version of the work published in the journal (for example, placing it in an institutional repository or publishing it in a book), with the recognition of having been first published in this journal.
Declaration of authorship: download here the Affidavit
